...
首页> 外文期刊>APMIS: Acta Pathologica, Microbiologica et Immunologica Scandinavica >Cyclin D1, p16(INK4A) and p27(Kip1) in pancreatic adenocarcinoma: assessing prognostic implications through quantitative image analysis
【24h】

Cyclin D1, p16(INK4A) and p27(Kip1) in pancreatic adenocarcinoma: assessing prognostic implications through quantitative image analysis

机译:Cyclin D1,P16(Ink4a)和P27(KIP1)在胰腺癌中:通过定量图像分析评估预后意义

获取原文
获取原文并翻译 | 示例

摘要

The prognostic significance of cyclin D1, p16(INK4A) and p27(Kip1) expression has been documented in several human malignancies; however, their prognostic potential in pancreatic adenocarcinoma is still unclear. This study aimed to assess the correlation of the aforementioned molecules with clinicopathological parameters and prognosis. Sixty patients with pancreatic ductal adenocarcinoma underwent surgical resection at a single institution; immunohistochemical staining of the studied markers was quantified by mage analysis system. Cyclin D1 overexpression was positively associated with grade, neural infiltration and vascular invasion, whereas p27 positively correlated with age. Higher cyclin D1 expression indicated poorer survival (adjusted HR=9.75, 95%CI: 1.48-64.31, p=0.018, increment: one unit in H-score), whereas a marginal trend toward an association between p16 positivity and improved survival was observed (adjusted HR=0.58, 95%CI: 0.32-1.05, p=0.072 regarding positive vs negative cases). No significant association with overall survival was noted regarding p27. In conclusion, cyclin D1 overexpression and possibly p16 loss of expression in pancreatic adenocarcinoma seem to be adverse prognostic factors, whereas p27 expression did not seem to possess such prognostic properties. Further validation of the present findings in studies encompassing larger samples seems to be needed.
机译:在几种人类恶性肿瘤中记录了细胞周期蛋白D1,P16(INK4A)和P27(KIP1)表达的预后意义;然而,它们在胰腺腺癌中的预后潜力尚不清楚。本研究旨在评估上述分子与临床病理参数和预后的相关性。 60例胰腺导管腺癌患者在单一机构接受手术切除术;通过法师分析系统量化研究标记的免疫组织化学染色。细胞周期蛋白D1过表达与等级,神经浸润和血管侵袭有阳性相关,而P27与年龄呈正相关。较高的细胞周期蛋白D1表达表明存活较差(调整后的HR = 9.75,95%CI:1.48-64.31,P = 0.018,增量:H-得分中的一个单元,而观察到P16积极性和改善存活之间的边际趋势(调整后的HR = 0.58,95%CI:0.32-1.05,P = 0.072关于阳性VS阴性病例)。关于P27,注意到与总生存率没有显着关联。总之,Cyclin D1过表达和可能P16在胰腺腺癌中表达的损失似乎是不良预后因素,而P27表达似乎没有具有这种预后性质。在包括较大样本的研究中进一步验证目前的研究结果似乎是必要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号